Testing Directly in Crude Samples
|Absolute Measurements
|Analyzing Particles up to 1,000 nm Dh
|Quantifying Exosomes in Fermentation Media
|Determining Stoichiometry
|Characterizing Liposomes
|Quantifying IgG in Raw Media
|Complying with all COVID-19 precautions, we are running at reduced pace, but, so far, our labs are still open with customer pilots and projects being run; samples are still received.
Join the Fidabio Mobilization
CSL Behring, Bern, adopted FIDA to perform accurate protein binding and concentration analysis directly in plasma and serum.
Fachhochschule, Basel, implemented a Fidabio instrument amongst others to carry out complex oligomeric analysis and develop comprehensive assays for determining molecular integrity.
The Jørgen Kjems Group at the Interdisciplinary Nanoscience Center at Aarhus University has after intensive testing implemented their first Fidabio instrument primarily for protein-nucleotide interactions analysis.
Fachhochschule, Basel, got their second Fidabio instrument.
DTU Bioengineering, Andreas H. Laustsen, has acquired a Fidabio system for high-throughput biophysical characterization of therapeutic antibodies etc.
Focus
Mobilize Your Research and Business
Applications
Mobilizing New insight
Quantitative data on complex protein binding, concentration, size etc.
Products
Mobilizing Accuracy
Speed up your decisions with fast development of specific assays.
Technology
Mobilizing a New Paradigm
Intuitive technology with high data reproducibility and built-in quality control.
The FIDA technology represents a revolution in the analysis of proteins and nanoparticles.
Join the new paradigm.
At Fidabio we are committed to assist you in accelerating your R&D projects. For this we have developed the FIDA technology enabling simple, accurate and fast detection and characterization of proteins & nanoparticles under native conditions.
